Loading…
Loading…
LVWD does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for LVWD and 80,000+ other tickers.
See exactly how LVWD's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for LVWD and 80,000+ other tickers.
LiveWorld, Inc. operates as both a digital agency and a software developer, delivering social media solutions primarily to the pharmaceutical, consumer packaged goods (CPG), and financial and travel industries. Their comprehensive services include expert consulting, strategic planning, and creative development. These are complemented by human-led teams focused on content moderation, community engagement, customer support, and managing adverse events. Additionally, the company provides proprietary conversation management software and AI-powered chatbots, all designed to enhance digital…
CAMPBELL, Calif. and NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for second quarter 2026.
Veteran healthcare creative leader brings deep pharmaceutical expertise and AI-driven innovation to expand agency capabilities Veteran healthcare creative leader brings deep pharmaceutical expertise and AI-driven innovation to expand agency capabilities
2026 Business Report reveals vision for the Intelligence Economy: Board signals confidence with planned stock purchases 2026 Business Report reveals vision for the Intelligence Economy: Board signals confidence with planned stock purchases
With 12 patents pending, the Human-Led, AI-Powered system delivers decision-grade insights — customized by disease state, brand, and user — in minutes, not weeks With 12 patents pending, the Human-Led, AI-Powered system delivers decision-grade insights — customized by disease state, brand, and user — in minutes, not weeks
Targets a long-overlooked gap in pharma marketing: the APP audience driving half of prescribing decisions Targets a long-overlooked gap in pharma marketing: the APP audience driving half of prescribing decisions